Drug
LY06006
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Active Trials
0(0%)
Phase Distribution
Ph phase_3
1
33%
Ph phase_1
2
67%
Phase Distribution
2
Early Stage
0
Mid Stage
1
Late Stage
Phase Distribution3 total trials
Phase 1Safety & dosage
2(66.7%)
Phase 3Large-scale testing
1(33.3%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Other(3)
Detailed Status
unknown3
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
N/A
Most Advanced
Phase 3
Trials by Phase
Phase 12 (66.7%)
Phase 31 (33.3%)
Trials by Status
unknown3100%
Recent Activity
0 active trials
Showing 3 of 3
unknownphase_3
A Study to Evaluate the Efficacy and Safety of LY06006 in Postmenopausal Women With Osteoporosis at High Risk for Fracture
NCT05060406
unknownphase_1
A Study to Evaluate LY06006 and Prolia in Healthy Adults
NCT04973722
unknownphase_1
A Study to Evaluate the Denosumab in Healthy Adults
NCT03427853
Clinical Trials (3)
Showing 3 of 3 trials
NCT05060406Phase 3
A Study to Evaluate the Efficacy and Safety of LY06006 in Postmenopausal Women With Osteoporosis at High Risk for Fracture
NCT04973722Phase 1
A Study to Evaluate LY06006 and Prolia in Healthy Adults
NCT03427853Phase 1
A Study to Evaluate the Denosumab in Healthy Adults
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3